Max Robotics — Global Service Robot Directory + US Certification

About

Xin-Gan Qin is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment. His work centers on comparing robotic and laparoscopic gastrectomy, aiming to define the optimal surgical approach for improved patient outcomes. Through large-scale, multicenter cohort studies, Dr. Qin has provided critical evidence on both short-term and long-term oncological results. His most influential paper, a 2024 study comparing robotic and laparoscopic gastrectomy, has garnered 23 citations, demonstrating significant impact in the field. He further solidified this contribution with a 2024 multicenter study on long-term outcomes (14 citations) and a 2025 investigation specifically addressing elderly patients (3 citations). Dr. Qin’s research is notable for its rigorous methodology and focus on clinically meaningful endpoints, such as three-year survival rates. His work directly addresses the ongoing debate over the superiority of robotic versus laparoscopic approaches, offering surgeons and patients data-driven guidance. By systematically evaluating these techniques across diverse patient populations, Dr. Qin is shaping the future of gastric cancer surgery, helping to refine standards of care and improve long-term survival for patients worldwide.